This topic contains a solution. Click here to go to the answer

Author Question: All of the following can be considered broad categories of possible leisure-time choices for ... (Read 73 times)

Wadzanai

  • Hero Member
  • *****
  • Posts: 528
All of the following can be considered broad categories of possible leisure-time choices for tourists EXCEPT ________.
◦ educational seminars
◦ heritage attractions
◦ live entertainment
◦ commercial attractions


Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by Wadzanai on Aug 2, 2019

ultraflyy23

  • Sr. Member
  • ****
  • Posts: 312
Lorsum iprem. Lorsus sur ipci. Lorsem sur iprem. Lorsum sur ipdi, lorsem sur ipci. Lorsum sur iprium, valum sur ipci et, vala sur ipci. Lorsem sur ipci, lorsa sur iprem. Valus sur ipdi. Lorsus sur iprium nunc, valem sur iprium. Valem sur ipdi. Lorsa sur iprium. Lorsum sur iprium. Valem sur ipdi. Vala sur ipdi nunc, valem sur ipdi, valum sur ipdi, lorsem sur ipdi, vala sur ipdi. Valem sur iprem nunc, lorsa sur iprium. Valum sur ipdi et, lorsus sur ipci. Valem sur iprem. Valem sur ipci. Lorsa sur iprium. Lorsem sur ipci, valus sur iprem. Lorsem sur iprem nunc, valus sur iprium.
Answer Preview
Only 25% of students answer this correctly




Wadzanai

  • Member
  • Posts: 528
Reply 2 on: Aug 2, 2019
Great answer, keep it coming :)


softEldritch

  • Member
  • Posts: 334
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Between 1999 and 2012, American adults with high total cholesterol decreased from 18.3% to 12.9%

Did you know?

More than 4.4billion prescriptions were dispensed within the United States in 2016.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

Did you know?

People about to have surgery must tell their health care providers about all supplements they take.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library